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Abstract
Background: Exposure to genotoxic stresses such as radiation and tobacco smoke can cause increased cancer 
incidence rate as reflected in an in depth meta-analysis of data for women and breast cancer incidence. Published 
reports have indicated that exposures to low dose radiation and tobacco smoke are factors that contribute to the 
development of breast cancer. However, there is a scarcity of information on the combinatorial effects of low dose 
radiation and tobacco smoke on formation and progression of breast cancer. The combination of these two genotoxic 
insults can induce significant damage to the genetic material of the cells resulting in neoplastic transformation.
Methods: To study the effects of low dose ionizing radiation and tobacco smoke on breast cells, MCF 10A cells were 
treated either with radiation (Rad - 0.1 Gray) or cigarette smoke condensate (Csc - 10 microgram/ml of medium) or a 
combination of Rad + Csc. Following treatments, cells were analyzed for cell cycle distribution patterns and the ability 
to extrude the Hoechst 33342 dye. In addition, in vitro invasion and migration as well as mammosphere formation 
assays were performed. Finally, differential gene expression profiles were generated from the individual and 
combination treatment.
Results: Exposure of MCF 10A cells to the combination of radiation plus cigarette smoke condensate generated a 
neoplastic phenotype. The transformed phenotype promoted increased mammosphere numbers, altered cell cycle 
phases with a doubling of the population in S phase, and increased invasion and motility. Also, exclusion of Hoechst 
33342 dye, a surrogate marker for increased ABC transporters, was observed, which indicates a possible increase in 
drug resistance. In addition, changes in gene expression include the up regulation of genes encoding proteins 
involved in metabolic pathways and inflammation.
Conclusions: The results indicate that when normal breast cells are exposed to low dose radiation in combination with 
cigarette smoke condensate a phenotype is generated that exhibits traits indicative of neoplastic transformation. More 
importantly, this is the first study to provide a new insight into a possible etiology for breast cancer formation in 
individuals exposed to low dose radiation and tobacco smoke.
Background
Women who are exposed to genotoxic stresses such as
radiation and tobacco smoke have increased cancer inci-
dence rate as reflected in an in depth meta-analysis of
data for cancer incidence [1-5]. In particular, flight atten-
dants exhibit an increased risk of breast and acute myel-
oid leukemia cancers [1] as they are exposed to long-term
doses of low-frequency electromagnetic fields [2-4]. It is
well established that doses of low energy radiation can
induce double stranded DNA breaks that result in altered
gene expression profiles in mammalian cells, which are
transmitted to later generations of progeny cells [6]. This
lateral transfer of aberrant genomic damage can acceler-
ate the DNA damage rate in subsequent generations,
which has been referred to as a radiation induced
bystander effect [7,8]. Low dose ionizing radiation has
also been shown to alter the intracellular production of
reactive oxygen species (ROS), such as, hydrogen perox-
ide, superoxide anion and hydroxyl radicals [9], which
induce mutations and chromosomal aberrations in cells
[10]. These types of genetic alterations can promote
many pathological conditions including those associated
with aging and cancer [11,12]. Such radiation also can
dysregulate the expression of stress related proteins and
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oncoproteins. For example, a number of cellular proteins
such as transcription factors (c-Jun, c-fos, IL1, egr-1), cell
cycle control (p53, cyclin A and B), and DNA metaboliz-
ing proteins (PCNA, β polymerase, PARP) have been
shown to be elevated following low dose irradiation [13-
17]. Hence, it can be inferred that long term exposure to
low dose ionizing radiation can initiate the carcinogene-
sis process [18].
Besides low dose radiation, there is also a growing body
of evidence supporting the hypothesis that exposure to
tobacco smoke is a contributing factor in neoplastic
transformation of breast cells [5]. Environmental tobacco
smoke has been shown to contain high amounts of poly-
c y c l i c  a r o m a t i c  h y d r o c a r b o n s  ( P A H s )  m a n y  o f  w h i c h
have been shown to be potent carcinogens [19-21]. In a
rat model, exposure to PAHs rapidly induced palpable
mammary tumors [22]. Histological analysis revealed a
high incidence of adenocarcinoma indicating the potent
carcinogenic property of PAHs. In addition, exposure of
human mammary epithelial cells (HMECs) and breast
cancer cell lines to an activated PAH: racemic anti-3,4-
dihydroxy-1,2-epoxy-1,2,3,4 tetrahydrobenzo phenan-
threne (BPDE), found in active and passive cigarette
smoke, exhibited altered cell cycle progression, decreased
BRCA-1 expression, an increased a spectrum of p53
mutations [23-26] and neoplastic transformation [5].
Additionally, BRCA1 and BRCA2 mutational carriers,
who are also smokers, are at an increased risk of getting
breast cancer [27]. In contrary, there is evidence to indi-
cate that active smoke does not increase risk of breast
cancer in a cohort Japanese women [28].
The combined effect of long-term human exposure to
cigarette smoke in combination with ionizing radiation is
not known. Thus, the purpose of this research was to
determine the combined effects of radiation and cigarette
smoke on the ontogeny of breast cancer formation and
progression. Towards this goal, we have found that expo-
sure of non-tumorigenic immortalized MCF 10A breast
cells to low dose radiation and cigarette smoke conden-
sate promoted a transformed phenotype. These results
provide a new insight into a possible etiology for breast
cancer formation in populations such as medical staff,
aircrews, nuclear test participants and nuclear industry
workers that are exposed to low dose radiation and simul-
taneously may have the likelihood to be exposed to active
and second hand cigarette smoke.
Methods
Cell culture and exposure to radiation and cigarette smoke 
condensate
MCF 10A cells (ATCC, Rockville, MD) were irradiated at
0.67 cGy/min to the desired dose (0.1 Gy) using a γ-cell
40 137Cesium irradiator (Atomic Energy of Canada). A 40
mg/ml stock solution of cigarette smoke condensate
(Murthy Pharmaceuticals, USA) was prepared in DMSO
and diluted with culture medium to a final concentration
of 10 mg/ml. Exponentially growing cells were first irradi-
ated and then exposed to Csc (10 μg/ml) for 72 hr [29].
Flow cytometry and immunoblot analysis
Determination of DNA content by flow cytometry was
performed as previously described [30]. Briefly, 2 × 106
MCF 10A cells were incubated for 72 hr following indi-
vidual and combined treatments. Fixed cells were incu-
bated with a staining solution containing 0.56% NP-40,
3.7% formaldehyde, and 0.01 mg/ml Hoechst 33258 in
phosphate-citrate buffered (pH 7.2) solution. DNA con-
t e n t  w a s  a n a l y z e d  b y  f l o w  c y t o m e t r y  i n s t r u m e n t a t i o n
(BD Biosciences, San Jose, CA).
F o r  i m m u n o b l o t  e x p e r i m e n t s ,  2 0  μ g  o f  t o t a l  c e l l u l a r
protein was subjected to SDS-PAGE. Membranes were
probed with the primary antibodies indicated in the fig-
ure legend.
Invasion and wound healing
Matrigel (100 μl; 7-8 mg/ml) in serum-free medium was
added to each well of a Transwell Corning Costar plate
(Costar, Acton, MA, USA) and dried overnight in a tissue
culture hood. The following day, 2.5 × 104 cells in serum-
free medium were pipetted onto the Matrigel and com-
plete medium was added to the bottom trough. Following
incubation, the transmembrane filter was stained with
crystal violet and the number of cells counted.
For wound healing, a small area was cleared along a
diameter of the 10 cm dishes of confluent monolayers of
MCF 10A and MCF 10A treated cells with a sterile
pipette tip. Cell migration was measured and photo-
graphed from the wound/scratch edge every 8 hr.
Hoechst 33342 dye exclusion assay
Following treatments, cells were incubated in 0.01 mg/ml
of Hoechst 33242 dye for 45 minutes and then washed
and incubated for a further 45 minutes and photographed
using the Nikon 80i fluorescent microscope. Fluores-
cence intensity per cell (blue channel) was analyzed using
image J software (n = 4 in each case).
Affymetrix analysis
RNA was extracted using the Qiagen mRNA extraction
kit. The RNA samples were analyzed with Affymetrix
GeneChip Human 133 2.0 Arrays. The quality of the
microarray experiments was assessed with affyPLM and
Affy, found at Bioconductor http://www.bioconduc-
tor.org. All computation was performed under R environ-
ment http://www.r-project.org. The Affy  software was
used to estimate the gene expression signals and evalu-
ated using the Robust Multi-array Average [31]. Data nor-
malization was performed using a Bayes method at
Bioconductor, which includes log normal modeling.Botlagunta et al. BMC Cancer 2010, 10:343
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EBarrays was used to estimate the posterior probabilities
of the differential expression of genes between the control
and treated sample [32,33]. This data has been deposited
with Gene Expression Omnibus (GEO-accession number
GSE21066).
Generation of mammospheres
Single cell suspensions (total 5000 cells in 2 ml) in Dul-
becco's modified Eagle's medium/F-12 containing 5 mg/
mL insulin, 0.5 mg/mL hydrocortisone, 2% B27 (Invitro-
gen Ltd., Paisley, Scotland), and 20 ng/mL epidermal
growth factor were seeded into ultra-low attachment
plates (Corning, Lowell, MA) and incubated for 7-10 days
in presence of 20% O2 and 5% CO2 at 37°C. Subsequently,
the number of mammospheres formed were counted
using a microscope.
Results
Effects of low dose ionizing radiation and cigarette smoke 
condensate on MCF 10A cells
The effect of low dose ionizing radiation and cigarette
smoke condensate was tested using MCF 10A normal
immortalized breast cells. Following treatments, we
observed differences between the morphological appear-
ances of the differently treated cultures. Single treatment
regimes generated consistent changes in cellular mor-
phologies relative to the untreated controls (Figure 1A).
Thus, irradiation or Csc treatment resulted in popula-
tions of cells with a rounded or slightly elongated mor-
phology (Figure 1A top right and lower left panels). In
contrast, combined treatment (Rad + Csc) of MCF 10A
cells generated a phenotype that was somewhat fibro-
blast-like (Figure 1A lower right panel), which grew with
fewer cell to cell contacts and was less cuboidal than the
parental cells. Flow cytometry analyses were performed
to evaluate whether the latter phenotypic changes could
be associated with a change in cell growth rate or cell
cycle frequency and hence a change in proliferation rate.
As shown in Figure 1B, irradiation (0.1 Gray) increased
the percentage of cells found in G2/M from the 3.7%
found in the untreated cells to 39.2% while Csc treatment
increased the percentage of cells in G0/G1 from 49%
found in untreated cells to 75.4%. Thus, irradiation did
not cause G1 arrest for MCF 10A cells while Csc treat-
ment caused G1 arrest. However, treatment of MCF 10A
cells with a combination of radiation plus Csc resulted in
42.9% of the cells being in S phase, which is roughly dou-
ble that of the untreated cells and provides an indication
that the combined treatment increased the percentage of
proliferating cells (Figure 1B). Subsequently, immunoblot
analyses were performed to investigate whether the cell
cycle changes mediated by genotoxic stress could be cor-
related to the expression of cell cycle regulatory proteins.
As indicated in Figure 1C, p53 protein levels were slightly
increased following low dose irradiation, which was
matched to an increase in the levels of its downstream
target p21. In contrast to Rad, Csc or a combination of
radiation plus Csc treatment resulted in a down regula-
tion of p53 and p21 levels (Figure 1C). This indicates that
Figure 1 Phenotypic characterization and cell cycle analyses of MCF 10A cells treated with radiation and cigarette smoke condensate. Pan-
el A - Photomicrographs of MCF 10A-Rad + Csc treated cells (elongated) as compared to the parental MCF 10A cells (cuboidal). Panel B - Shows the 
percentage of cells distributed at the different phases of the cell cycle. Panel C - Immunoblot analyses of cell extracts from the control and treated 
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Rad + Csc can alter the levels of regulatory molecules to
dysregulate phases of the cell cycle.
Migration and invasive capabilities of treated MCF 10A cells
Increased cell motility and invasion are characteristics of
a neoplastic transformation. To test whether the geno-
toxic stresses used in our experimental setting could
increase the migration of MCF 10A cells, we used a
scratch/wound assay. As shown in Figure 2A, MCF 10A
cells treated with Rad as well as Rad + Csc were able to
migrate into the cleared area within 24 hr of incubation.
On the other hand, untreated and Csc treated MCF 10A
cells showed little migration into the cleared region dur-
ing this time period. W e next investigated the effect of
radiation and Csc on cell invasion in a modified Boyden
chamber assay. As depicted in Figure 2B, MCF 10 A cells
treated with Csc lack the ability to invade whereas Rad or
the combination Rad + Csc cells were extremely invasive
(four fold increase) as compared to the untreated and Csc
treated MCF 10A cells. Taken together these data indi-
cate that the Rad as well as Rad + Csc treated cells
acquired genetic/biochemical alterations that increased
the cells ability to migrate and invade, i.e., a possible
increase in dissemination or metastatic potential.
MCF 10A treated cells exhibit increase efflux of Hoechst 
33342 dye
A distinct characteristic of a metastatic phenotype is gen-
erally increased drug resistant properties. Some of the
pathways that promote drug resistance are elevated
expression of ATP-binding cassette (ABC) glycoprotein
transporters at the cell surface [34]. The elevated expres-
sion of these transporters can exclude vital dyes such as
Hoechst 33342 analogues to chemotherapeutic drugs,
thus promoting multi-drug resistance. As MCF 10A cells
treated with Rad + Csc induced a transformed pheno-
type, we evaluated the ability of these cells to extrude the
Hoechst 33342 dye, a surrogate marker for drug uptake.
As seen in Figure 2C &2D, cells treated with both Rad +
Csc retained less dye as compared to the untreated MCF
Figure 2 Invasion and wound healing assays of the treated MCF 10A cells. Panel A - In vitro wound healing assay. A filling of the cleared area, as 
demarcated by the horizontal red lines, was followed microscopically at 20× magnification. Panel B - Bar graph quantifying invasion of treated and 
untreated MCF 10A cells using Boyden chambers (means, n = 2). Panel C - Efflux of Hoechst 33342 in MCF 10A treated cells. Inset shows 40× magni-
fication of representative cells. Panel D - Bar graph showing quantification of the fluorescence intensity per cell in the blue channel.
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10A cells. This indicates that the combination treatment
in MCF 10A cells can induce a drug resistant phenotype.
Changes in gene expression profile and mammosphere 
formation following genotoxic stress
In an effort to determine which genes might be contribut-
ing to the increased cell invasion and migration capabili-
ties of Rad or Rad + Csc treated MCF 10A cells, we
performed expression analyses using the Affymetrix plat-
form. To identify differentially expressed gene sets fol-
lowing treatment, we compared the individual (Rad or
Csc) treatment data sets with the combined treatment
(Rad + Csc) data set using a Venn diagram (Figure 3A).
The Venn diagram indicates that 53 genes differentially
expressed in the combination treated cells compared to
untreated cells. Among these, 18 genes (12 up regulated
and 6 down regulated) have been reported as participat-
ing in cellular pathways of cancer (Figure 3B). Included in
this group were genes involved in tissue remodeling,
metabolism and cell adhesion molecules. One cell adhe-
sion molecule identified was CD44, which has been
directly correlated to human breast cancer grade [35].
Moreover, a high CD44 low CD24 expression profile in
breast cancer cell lines has been associated with a puta-
tive breast cancer initiating cell phenotype [36]. In order
to validate the microarray data, we estimated the CD44
levels in treated versus untreated cell lines. The expres-
sion level of CD44 was up regulated 2 fold in the com-
bined treatment as compared to the untreated and Rad
treated (Figure 3C). Recently, cells exhibiting a high CD44
low CD24 expression profile have been shown to form
mammospheres in culture conditions, which were resis-
tant to chemotherapeutic regimes [37]. Therefore, we
investigated the effect of genotoxic stress on MCF 10A
cells to form mammospheres in vitro. Figure 4A shows
representative mammosphere images under different
genotoxic stress. The combined treated cells formed the
most number of mammospheres as compared to individ-
ual treatments (Figure 4B). Thus, the Affymetrix data
indicates that the combined treatment can initiate gene
expression patterns that are associated with known can-
cers. That along with enhanced mammosphere formation
Figure 3 Differential gene expression pattern in MCF 10A cells following genotoxic stress. Panel A - Venn diagram depicting the total number 
of genes that intersect following exposure of MCF 10 A cells to Rad, Csc and Rad + Csc. Panel B - Select set of up and down regulated genes, at 72 hr 
following treatment, that intersect in Rad + Csc conditions. Panel C - CD44 and CD24 levels as determined by the real time PCR from RNA samples 
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Kv channel interacting protein 2 1.6 Ion transport
Cytochrome P450, family 1  2 Estrogen metabolism
FXYD domain containing ion transport regulator 3 1.6 Chloride conductance
S100 calcium binding protein A8 2.2 Inflammatory response
S100 calcium binding protein A9 1.8 Inflammatory response
Aldehyde dehydrogenase 3 family, memberA1 1.7 Steroid metabolism
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Versican 1.6 Cell proliferation
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Follistatin -1.6 Signal transduction
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strengthens our suggestion that further experiments will
indicate that the altered gene profiles are consistent rep-
resentations of known cancer cell phenotypes.
Discussion
Long-term exposure to low dose radiation at levels that
can damage normal cell functions and propagate dsyreg-
ulated molecular programs can generate diseased tissue.
For example, aircrews, medical staff and workers in the
nuclear energy industry are often exposed to low dose
radiation as well as cigarette smoke and the combined
effect of these two environmental stresses likely identifies
these as a few of the populations that have an increased
risk of developing cancer. As low dose radiation and ciga-
rette smoke exposure may very well alter the breast tissue
biochemistry, physiology, and morphology, it is essential
to determine if the combined effects of such exposures
induces genetic/biochemical alterations that can trigger
breast tumor formation. Such considerations led us to
study the action of the combined environmental geno-
toxic stresses of low dose radiation and cigarette smoke
condensate on immortalized non-tumorigenic breast epi-
thelial cells, MCF 10A. The finding that exposing cells to
both Rad + Csc generated cells that exhibited a fibroblas-
tic phenotype, which is different from the normal cuboi-
dal shaped MCF 10A cells, is a clear indication that
fundamental genetic alterations occurred during treat-
ment. The low dose irradiation used in this study induced
cell cycle arrest (G2/M), which is in agreement with this
well known effect occurring in cells exposed to radiation
[38]. Although, we observed only marginal increases in
p53 and p21, these changes nevertheless support the
known function of these proteins in this check point pro-
cess [39]. However, Csc and combined treated cells
reversed or abrogated the check point response to ioniz-
ing radiation and caused a shift in cell cycle to G0/G1 and
S phase respectively with concomitant decreases in p53
and p21. The alterations in the cell cycle distribution pat-
tern following combined treatment indicates that a com-
bination of genotoxic exposures is more detrimental with
respect to the generation of a proliferating phenotype
then either single exposure under the conditions used
here.
Tumorigenesis is a complex process and it involves
intricate biological mechanisms such as invasion and
motility that are essential attributes of metastasis [40].
We observed that Rad or Rad + Csc doubled the percent-
age of cells that invaded the Matrigel. We have further
demonstrated that exposure of MCF 10A cells to low
dose radiation followed by Csc altered the transcription
profiles of a number of genes that fell into two broad cate-
gories: (1) those with common responses across individ-
ual treatments and (2) those with differential responses
associated with combined treatment. Our study is the
first genome-wide analysis of transcript profiles associ-
ated with concomitant radiation and cigarette smoke
condensate exposures. The major changes associated
with the differential response can be categorized as those
c e l l u l a r  p r o p e r t i e s  a s s o c i a t e d  w i t h  t i s s u e  r e m o d e l i n g ,
metabolism, and altered cell membrane protein levels,
while a more ambiguous outcome was observed for genes
involved in inflammation and signaling events. Our find-
ings of increased transcript levels in a large number of
metabolic genes appear to indicate that metabolism is an
important component of stress response mechanisms
after exposure to radiation or Csc. An increase in Cyto-
chrome P450 observed in Rad + Csc treated cells may
metabolically activate the carcinogens present in ciga-
Figure 4 Mammosphere formation of MCF 10A cells treated with radiation and cigarette smoke condensate. Panel A - Photomicrographs of 
the mammospheres following treatment with Rad, Csc and Rad + Csc. Panel B - Shows the total number of mammospheres following exposure to 
Rad, Csc and Rad + Csc. The counts represented are averages from two independent experiments.
A) Untreated Rad
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rette smoke within the breast environment to promote
carcinogenesis. Furthermore, cell membrane proteins
have been previously reported to be elevated after low
dose radiation exposures [41]. The significant changes in
the expression level of CD44 and mammosphere number
induced by Rad + Csc supports the generation of radio-
resistant phenotype as compared to individual treated
fraction [37].
Although a direct correlation of results obtained on
cultured human cells to the human situation requires
additional research, we envisage that the results of the
present study will help initiate further studies on the
affects of long term human exposure to low dose radia-
tion and tobacco smoke in the pathogenesis of breast can-
cer.
Conclusions
In conclusion, we have demonstrated that short term
exposure of normal breast cells to low doses of ionizing
radiation and the potent carcinogens in tobacco smoke
condensate can induce genetic and phenotypic changes
that reflect those of known cancer cell types. Given the
limitations of these in vitro studies and the complexities
of translating these findings to real life responses to such
environmental mutagens and carcinogens is a strong
indication that further investigation will be required to
conclusively demonstrate the risk of getting breast cancer
following exposure to low dose radiation and cigarette
smoke. Still this is the first study to demonstrate the
effects of low dose ionizing radiation in combination with
exposures to tobacco smoke carcinogens that can result
in a possible initiation of cellular processes that give rise
to breast cancer cells.
Abbreviations
Rad: radiation; Csc: cigarette smoke condensate; ABC: ATP-binding cassette;
ROS: reactive oxygen species.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
MB collected and analyzed the data and drafted the manuscript. PW helped in
the data analysis and manuscript writing. VR conceived the study and partici-
pated in data analysis, interpretation and manuscript writing. All authors have
read and approved the final manuscript.
Acknowledgements
This work was supported by a grant from the Flight Attendant Medical 
Research Institute to Venu Raman.
Author Details
1Department of Radiology, Johns Hopkins University School of Medicine, 
Baltimore, Maryland, USA and 2Department of Oncology, Johns Hopkins 
University School of Medicine, Baltimore, Maryland, USA
References
1. Ballard T, Lagorio S, De Angelis G, Verdecchia A: Cancer incidence and 
mortality among flight personnel: a meta-analysis.  Aviat Space Environ 
Med 2000, 71(3):216-224.
2. Nicholas JS, Lackland DT, Dosemeci M, Mohr LC Jr, Dunbar JB, Grosche B, 
Hoel DG: Mortality among US commercial pilots and navigators.  J 
Occup Environ Med 1998, 40(11):980-985.
3. Lim MK: Exposure of airline pilots and cabin crew to cosmic radiation 
during flight--what's the fuss?  Ann Acad Med Singapore 2001, 
30(5):494-498.
4. Kojo K, Helminen M, Leuthold G, Aspholm R, Auvinen A: Estimating the 
cosmic radiation dose for a cabin crew with flight timetables.  J Occup 
Environ Med 2007, 49(5):540-545.
5. Botlagunta M, Vesuna F, Mironchik Y, Raman A, Lisok A, Winnard P Jr, 
Mukadam S, Van Diest P, Chen JH, Farabaugh P, et al.: Oncogenic role of 
DDX3 in breast cancer biogenesis.  Oncogene 2008, 27(28):3912-3922.
6. Goodhead DT: Initial events in the cellular effects of ionizing radiations: 
clustered damage in DNA.  Int J Radiat Biol 1994, 65(1):7-17.
7. Little JB: Genomic instability and bystander effects: a historical 
perspective.  Oncogene 2003, 22(45):6978-6987.
8. Mothersill C, Seymour C: Radiation-induced bystander and other non-
targeted effects: novel intervention points in cancer therapy?  Curr 
Cancer Drug Targets 2006, 6(5):447-454.
9. Narayanan PK, Goodwin EH, Lehnert BE: Alpha particles initiate 
biological production of superoxide anions and hydrogen peroxide in 
human cells.  Cancer Res 1997, 57(18):3963-3971.
10. Brooks AL: Paradigm shifts in radiation biology: their impact on 
intervention for radiation-induced disease.  Radiat Res 2005, 164(4 Pt 
2):454-461.
11. Finkel T, Holbrook NJ: Oxidants, oxidative stress and the biology of 
ageing.  Nature 2000, 408(6809):239-247.
12. Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow?  
Lancet 2001, 357(9255):539-545.
13. FitzGerald TJ, Santucci MA, Das I, Kase K, Pierce JH, Greenberger JS: The v-
abl, c-fms, or v-myc oncogene induces gamma radiation resistance of 
hematopoietic progenitor cell line 32d cl 3 at clinical low dose rate.  Int 
J Radiat Oncol Biol Phys 1991, 21(5):1203-1210.
14. Miller AC, Gafner J, Clark EP, Samid D: Differences in radiation-induced 
micronuclei yields of human cells: influence of ras gene expression and 
protein localization.  Int J Radiat Biol 1993, 64(5):547-554.
15. Chang EH, Pirollo KF, Zou ZQ, Cheung HY, Lawler EL, Garner R, White E, 
Bernstein WB, Fraumeni JW Jr, Blattner WA: Oncogenes in radioresistant, 
noncancerous skin fibroblasts from a cancer-prone family.  Science 
1987, 237(4818):1036-1039.
16. Kasid UN, Weichselbaum RR, Brennan T, Mark GE, Dritschilo A: 
Sensitivities of NIH/3T3-derived clonal cell lines to ionizing radiation: 
significance for gene transfer studies.  Cancer Res 1989, 
49(12):3396-3400.
17. Hanna E, Shrieve DC, Ratanatharathorn V, Xia X, Breau R, Suen J, Li S: A 
novel alternative approach for prediction of radiation response of 
squamous cell carcinoma of head and neck.  Cancer Res 2001, 
61(6):2376-2380.
18. Barcellos-Hoff MH, Park C, Wright EG: Radiation and the 
microenvironment - tumorigenesis and therapy.  Nat Rev Cancer 2005, 
5(11):867-875.
19. Egan KM, Stampfer MJ, Hunter D, Hankinson S, Rosner BA, Holmes M, 
Willett WC, Colditz GA: Active and passive smoking in breast cancer: 
prospective results from the Nurses' Health Study.  Epidemiology 2002, 
13(2):138-145.
20. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR: Exposure of 
the US population to environmental tobacco smoke: the Third 
National Health and Nutrition Examination Survey, 1988 to 1991.  Jama 
1996, 275(16):1233-1240.
21. Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen 
D, Horn-Ross PL, Peel D, Pinder R, Ross RK, et al.: Active smoking, 
household passive smoking, and breast cancer: evidence from the 
California Teachers Study.  J Natl Cancer Inst 2004, 96(1):29-37.
22. Hecht SS: Tobacco smoke carcinogens and breast cancer.  Environ Mol 
Mutagen 2002, 39(2-3):119-126.
23. Wang A, Gu J, Judson-Kremer K, Powell KL, Mistry H, Simhambhatla P, 
Aldaz CM, Gaddis S, MacLeod MC: Response of human mammary 
Received: 31 August 2009 Accepted: 30 June 2010 
Published: 30 June 2010
This article is available from: http://www.biomedcentral.com/1471-2407/10/343 © 2010 Botlagunta et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Cancer 2010, 10:343Botlagunta et al. BMC Cancer 2010, 10:343
http://www.biomedcentral.com/1471-2407/10/343
Page 8 of 8
epithelial cells to DNA damage induced by BPDE: involvement of novel 
regulatory pathways.  Carcinogenesis 2003, 24(2):225-234.
24. Burdick AD, Ivnitski-Steele ID, Lauer FT, Burchiel SW: PYK2 mediates anti-
apoptotic AKT signaling in response to benzo[a]pyrene diol epoxide in 
mammary epithelial cells.  Carcinogenesis 2006, 27(11):2331-2340.
25. Jeffy BD, Chirnomas RB, Chen EJ, Gudas JM, Romagnolo DF: Activation of 
the aromatic hydrocarbon receptor pathway is not sufficient for 
transcriptional repression of BRCA-1: requirements for metabolism of 
benzo[a]pyrene to 7r,8t-dihydroxy-9t,10-epoxy-7,8,9,10-
tetrahydrobenzo[a]pyrene.  Cancer Res 2002, 62(1):113-121.
26. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P: 
Tobacco smoke carcinogens, DNA damage and p53 mutations in 
smoking-associated cancers.  Oncogene 2002, 21(48):7435-7451.
27. Smoking and risk of breast cancer in carriers of mutations in BRCA1 or 
BRCA2 aged less than 50 years.  Breast Cancer Res Treat 2008, 
109(1):67-75.
28. Lin Y, Kikuchi S, Tamakoshi K, Wakai K, Kondo T, Niwa Y, Yatsuya H, Nishio 
K, Suzuki S, Tokudome S, et al.: Active smoking, passive smoking, and 
breast cancer risk: findings from the Japan Collaborative Cohort Study 
for Evaluation of Cancer Risk.  J Epidemiol 2008, 18(2):77-83.
29. Kundu CN, Balusu R, Jaiswal AS, Gairola CG, Narayan S: Cigarette smoke 
condensate-induced level of adenomatous polyposis coli blocks long-
patch base excision repair in breast epithelial cells.  Oncogene 2007, 
26(10):1428-1438.
30. Gajewski E, Gaur S, Akman SA, Matsumoto L, van Balgooy JN, Doroshow 
JH: Oxidative DNA base damage in MCF-10A breast epithelial cells at 
clinically achievable concentrations of doxorubicin.  Biochem 
Pharmacol 2007, 73(12):1947-1956.
31. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, 
Speed TP: Exploration, normalization, and summaries of high density 
oligonucleotide array probe level data.  Biostatistics 2003, 4(2):249-264.
32. Newton MA, Kendziorski CM, Richmond CS, Blattner FR, Tsui KW: On 
differential variability of expression ratios: improving statistical 
inference about gene expression changes from microarray data.  J 
Comput Biol 2001, 8(1):37-52.
33. Kendziorski CM, Newton MA, Lan H, Gould MN: On parametric empirical 
Bayes methods for comparing multiple groups using replicated gene 
expression profiles.  Stat Med 2003, 22(24):3899-3914.
34. Hadnagy A, Gaboury L, Beaulieu R, Balicki D: SP analysis may be used to 
identify cancer stem cell populations.  Exp Cell Res 2006, 
312(19):3701-3710.
35. Diaz LK, Zhou X, Wright ET, Cristofanilli M, Smith T, Yang Y, Sneige N, Sahin 
A, Gilcrease MZ: CD44 expression is associated with increased survival 
in node-negative invasive breast carcinoma.  Clin Cancer Res 2005, 
11(9):3309-3314.
36. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: 
Prospective identification of tumorigenic breast cancer cells.  Proc Natl 
Acad Sci USA 2003, 100(7):3983-3988.
37. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, 
Pavlick A, Zhang X, Chamness GC, et al.: Intrinsic resistance of 
tumorigenic breast cancer cells to chemotherapy.  J Natl Cancer Inst 
2008, 100(9):672-679.
38. Janicke RU, Engels IH, Dunkern T, Kaina B, Schulze-Osthoff K, Porter AG: 
Ionizing radiation but not anticancer drugs causes cell cycle arrest and 
failure to activate the mitochondrial death pathway in MCF-7 breast 
carcinoma cells.  Oncogene 2001, 20(36):5043-5053.
39. Hofseth LJ: The adaptive imbalance to genotoxic stress: genome 
guardians rear their ugly heads.  Carcinogenesis 2004, 25(10):1787-1793.
40. Winnard PT Jr, Pathak AP, Dhara S, Cho SY, Raman V, Pomper MG: 
Molecular imaging of metastatic potential.  J Nucl Med 2008, 49(Suppl 
2):96S-112S.
41. Coleman MA, Yin E, Peterson LE, Nelson D, Sorensen K, Tucker JD, 
Wyrobek AJ: Low-dose irradiation alters the transcript profiles of 
human lymphoblastoid cells including genes associated with 
cytogenetic radioadaptive response.  Radiat Res 2005, 164(4 Pt 
1):369-382.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2407/10/343/prepub
doi: 10.1186/1471-2407-10-343
Cite this article as: Botlagunta et al., Neoplastic transformation of breast epi-
thelial cells by genotoxic stress BMC Cancer 2010, 10:343